Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
01 1Supriya Lifescience Limited
01 1Dexbrompheniramine Maleate
01 1India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
NDC Package Code : 61281-4000
Start Marketing Date : 2013-11-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Dexbrompheniramine Maleate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dexbrompheniramine Maleate, including repackagers and relabelers. The FDA regulates Dexbrompheniramine Maleate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dexbrompheniramine Maleate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dexbrompheniramine Maleate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dexbrompheniramine Maleate supplier is an individual or a company that provides Dexbrompheniramine Maleate active pharmaceutical ingredient (API) or Dexbrompheniramine Maleate finished formulations upon request. The Dexbrompheniramine Maleate suppliers may include Dexbrompheniramine Maleate API manufacturers, exporters, distributors and traders.
click here to find a list of Dexbrompheniramine Maleate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dexbrompheniramine Maleate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dexbrompheniramine Maleate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dexbrompheniramine Maleate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dexbrompheniramine Maleate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dexbrompheniramine Maleate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dexbrompheniramine Maleate suppliers with NDC on PharmaCompass.
We have 1 companies offering Dexbrompheniramine Maleate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
